| 发明名称 |
INTRACAMERAL SUSTAINED RELEASE THERAPEUTIC AGENT IMPLANTS |
| 摘要 |
Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye. |
| 申请公布号 |
US2017071853(A1) |
申请公布日期 |
2017.03.16 |
| 申请号 |
US201615362197 |
申请日期 |
2016.11.28 |
| 申请人 |
Allergan, Inc. |
发明人 |
Robinson Michael R.;Burke James A.;Schiffman Rhett M;Ghebremeskel Alazar N. |
| 分类号 |
A61K9/00;A61K47/34;A61K47/10;A61K31/5575 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for treating an ocular condition comprising the steps of:
providing at least two biodegradable sustained release implants containing travoprost or a salt thereof; implanting the at least two biodegradable sustained release implants into the anterior chamber of an eye; and treating the ocular condition, wherein the at least two biodegradable sustained release implants release about 100 ng per day of the travoprost or a salt thereof for a period greater than about 1 month. |
| 地址 |
Irvine CA US |
